ACETATED RINGER'S IN PLASTIC CONTAINER
Clinical safety rating: caution
Comprehensive clinical and safety monograph for ACETATED RINGER'S IN PLASTIC CONTAINER (ACETATED RINGER'S IN PLASTIC CONTAINER).
Acetated Ringer's solution provides isotonic crystalloid fluid and electrolytes, with acetate as a bicarbonate precursor metabolized in the liver and peripheral tissues, buffering metabolic acidosis. It restores intravascular volume and corrects electrolyte imbalances.
| Metabolism | Acetate is metabolized via acetyl-CoA in the tricarboxylic acid cycle, yielding bicarbonate; primary sites include liver and skeletal muscle. |
| Excretion | Acetated Ringer's solution components are excreted primarily renally: water (100% via kidneys), sodium (90-95% renal, 5-10% sweat/feces), chloride (90-95% renal), acetate (metabolized to bicarbonate, then CO2 excreted via lungs; <5% renal), potassium (80-90% renal, 10-20% feces), calcium (98% renal reabsorption, <2% fecal), magnesium (70% renal, 30% fecal). |
| Half-life | Not applicable as a fixed half-life; components distribute and equilibrate rapidly. For administered volume, intravascular half-life is 20-30 minutes due to redistribution to interstitial space. Electrolyte half-lives: sodium ~8-12 hours, chloride ~8-12 hours, potassium ~12-24 hours, calcium ~24-48 hours, magnesium ~24-48 hours. |
| Protein binding | Calcium: ~40% bound to albumin; magnesium: ~30% bound to albumin; other components (sodium, potassium, chloride, acetate) have negligible protein binding (<5%). |
| Volume of Distribution | Not a single value for all components. Water distributes into total body water (0.6 L/kg), sodium and chloride primarily into extracellular fluid (0.2 L/kg), potassium into intracellular fluid (0.4 L/kg), calcium and magnesium into bone and cells (Vd ~0.5-0.8 L/kg). |
| Bioavailability | Intravenous: 100% (only route administered). Oral: not applicable; not administered orally. |
| Onset of Action | Intravenous: immediate (within seconds) for volume expansion; electrolyte effects begin within minutes. |
| Duration of Action | Intravenous: volume effects last 30-60 minutes for 1 L infusion under normal conditions; longer in hypovolemia. Electrolyte effects persist for hours to days depending on excretion/regulation, e.g., potassium repletion duration ~2-4 hours after infusion. |
Intravenous infusion; dosing based on patient's fluid and electrolyte needs. Typical adult dose: 500-1000 mL per hour as needed for volume replacement; adjust rate based on clinical response and serum electrolyte monitoring.
| Dosage form | INJECTABLE |
| Renal impairment | No specific GFR-based dose adjustment required; however, use with caution in renal impairment due to risk of fluid overload and electrolyte imbalances. Monitor serum potassium and renal function. |
| Liver impairment | No specific Child-Pugh dose adjustment; use with caution in severe hepatic impairment due to potential altered lactate metabolism. Monitor electrolytes and acid-base status. |
| Pediatric use | Weight-based dosing: 20-30 mL/kg as a bolus over 30-60 minutes for volume expansion; maintenance: adjust based on fluid deficit and ongoing losses. Maximum rate and volume vary by clinical condition. |
| Geriatric use | Consider reduced initial volume and slower infusion rate due to decreased cardiovascular reserve and higher risk of fluid overload. Monitor closely for signs of heart failure and electrolyte disturbances. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for ACETATED RINGER'S IN PLASTIC CONTAINER (ACETATED RINGER'S IN PLASTIC CONTAINER).
| Breastfeeding | Considered safe during breastfeeding; components (sodium, chloride, potassium, calcium, acetate) are normal physiological constituents. M/P ratio not applicable. |
| Teratogenic Risk | No fetal risks identified; acetated Ringer's solution is isotonic and used for fluid and electrolyte replenishment. No teratogenic effects reported in any trimester. |
| Fetal Monitoring |
■ FDA Black Box Warning
Not available; no FDA boxed warning.
| Serious Effects |
Hypernatremia, hyperkalemia, hypercalcemia, metabolic alkalosis, severe renal failure with oliguria/anuria, and known hypersensitivity to any component.
| Precautions | Monitor serum electrolytes and acid-base status; avoid in patients with severe renal impairment or alkalosis; caution in heart failure, pulmonary edema, and conditions causing sodium retention. |
| Food/Dietary | No specific food interactions. However, dietary intake of sodium and potassium should be considered in patients with electrolyte imbalances or renal impairment. |
| Clinical Pearls |
Loading safety data…
| Monitor maternal fluid balance, serum electrolytes, acid-base status, and urine output; fetal heart rate monitoring if indicated by maternal condition. |
| Fertility Effects | No known effects on fertility; used as a physiological solution without reproductive toxicity. |
| Acetated Ringer's is an isotonic crystalloid containing acetate as a bicarbonate precursor; it does not require hepatic metabolism for alkalinization, unlike lactate, making it preferable in patients with hepatic impairment or lactic acidosis. Monitor serum electrolytes and acid-base status during infusion, especially in renal impairment. Do not administer through same IV line with blood products due to risk of hemolysis from calcium content. Avoid use in metabolic alkalosis. |
| Patient Advice | This solution is used to replace body fluids and electrolytes, often during surgery or dehydration. · Tell your doctor if you have kidney disease, heart failure, or are on a sodium-restricted diet. · You may experience swelling if too much fluid is given; report shortness of breath or leg swelling. · Notify your healthcare provider if you feel dizzy, have muscle cramps, or tingling sensations. · Do not suddenly stop treatment without consulting your doctor. |